Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05060016 |
|---|---|
| Brief Title: | A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) (DeLLphi-301) |
| First Submitted : | September 17, 2021 |
| First Submitted that Met QC Criteria : | September 17, 2021 |
| First Posted : | September 28, 2021 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |